Simulix Evolution™ Addresses the Needs of Parkridge Medical Center

March 8 2005  

Veenendaal, The Netherlands,  – Nucletron B.V., a global leader providing some of the world’s most innovative products and services for cancer treatment, recently installed a Simulix Evolution simulator for radiation therapy, at Parkridge Medical Center in Chattanooga, Tennessee.


Dr. Noel Scidmore, Director of the Sarah Cannon Cancer Center at Parkridge, impressed by the reliability of Simulix Evolution since it was installed, stated,  “Simulix Evolution is very well designed. We have not had a single down day since installation approximately four months ago.”


“We were extremely pleased with all features of the machine, and I consider this to be the most advanced simulator on the world market at this time,” continues Dr. Scidmore. “I have also used simulators from other vendors and the Simulix Evolution is hands down the most reliable and advanced simulator I have ever worked with.”


Simulix Evolution exposes the patient to less unnecessary doses of radiation than other simulators, by eliminating the need for continuous scanning and image merge required on other systems. This capability is enabled by the largest amorphous silicon digital viewing area of any simulator. “The image quality is superior to any simulator I have seen, and the multiple features are also quite accommodating to our patient needs,” said Dr. Scidmore, mirroring the confidence of the hospital’s clinical specialists in the unsurpassed quality of images used for treatment planning. 


The creation and validation of the multi-leaf collimator (MLC) modernizes the simulation process, embedding new functionality into the simulator.  Additionally, support for DICOM RT Import/Export means that critical information can flow throughout the department, which streamlines the radiotherapy treatment process. 


“We can design multi-leaf collimation fields on the simulator and transmit those directly to our treatment planning machine. This has facilitated our work in emergency starts and simulations,” said Dr. Scidmore.


Nucletron refreshes the simulator with new technologies to keep it innovative.   “We offer the latest advances in digital imaging to our customers with simulators installed, something no other company does,” said Kim Chambers, Product Manager, Imaging Devices for Nucletron Corporation. “This ensures a positive and timely return on investment, with the added assurance that with Nucletron it is possible to add future technology to an existing simulator.”


 “Given the outstanding service, reliability, and features this machine has afforded us, I would recommend this machine over any simulator available on the market today, at any cost” affirmed Dr. Scidmore.



About Parkridge Medical Center and Sarah Cannon Cancer Center

Parkridge Medical Center is part of the TriStar Health System, a network of 14 HCA hospitals across Tennessee and southern Kentucky. HealthGrades ranked Parkridge Medical Center No. 1 in Tennessee and among the top 5 percent in the nation for overall orthopaedic services.  The facility is also recognized as one of Solucient’s   100 Top Hospitals for 2005. For more information about the services offered and health plans accepted by TriStar Health System, please call (800) 242-5662 or visit our website at TriStarHealth.com.


The Sarah Cannon Cancer Center (SCCC) is a network of TriStar facilities that provides diagnosis and treatment to cancer patients. All of facilities operate cooperatively to provide state-of-the-art diagnostic tests as well as the latest treatment modalities. Founded in 1991, the center was named after the legendary performer following her cancer diagnosis and treatment at a TriStar hospital.



About Nucletron B.V.
Nucletron is a global leader in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment, with particular expertise in treatment planning systems, brachytherapy, simulation, integrated software solutions for oncology, and comprehensive support and professional education and services. The company has over 20 offices worldwide, including its corporate headquarters in Veenendaal, the Netherlands. For more information on Nucletron, please visit: http://www.nucletron.com/.


Nucletron B.V. is a subsidiary of Delft Instruments. Delft Instruments is the holding company of an international group of companies, which hold a leading position in their respective markets with high quality, high technology products and services. Delft Instruments employs approximately 1,200 people and reported net profit of EUR 10.4 million on turnover of EUR 237 million in 2003. For more information on Delft Instruments, please visit: http://www.delftinstruments.com/ 

For further information: